These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 713173)

  • 41. [Reduction of calcium transfer to body with high sodium dialysate (author's transl)].
    Sezaki R; Shinzato T; Maeda K; Asada H; Kawaguchi S; Usuda M; Ohbayashi S
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1421-5. PubMed ID: 7334722
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prophylactic effects of 5,6-trans-25hybroxycholecalciferol on acute oral cadmium intoxication (author's transl)].
    Kojima R
    Jikken Dobutsu; 1974 Jan; 23(1):37-9. PubMed ID: 4368237
    [No Abstract]   [Full Text] [Related]  

  • 43. 1alpha-hydroxycholecalciferol and renal function.
    Lund B; Sørensen OH; Lund B
    Lancet; 1978 Sep; 2(8092 Pt 1):731. PubMed ID: 80649
    [No Abstract]   [Full Text] [Related]  

  • 44. About the association between high alkaline phosphatase and risk of death and hospitalization in dialysis patients.
    Baakrim A; Shahapuni I; Rouached M; Fournier A
    Kidney Int; 2009 May; 75(10):1114; author reply 1114. PubMed ID: 19404286
    [No Abstract]   [Full Text] [Related]  

  • 45. [The influence of immobilisation on the alcaline phosphatase activity from adults and children (author's transl)].
    Schmitt O
    Arch Orthop Unfallchir; 1976 Jun; 85(1):81-5. PubMed ID: 938316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter: 1alpha-H.C.C. in chronic renal failure.
    Brancaccio D; Faccini JM; Graziani G
    Lancet; 1976 Jun; 1(7974):1418. PubMed ID: 59066
    [No Abstract]   [Full Text] [Related]  

  • 47. [Indirect determination of N-nitrosocyclohexylsulfamic acid in serum after oral application to rats (author's transl].
    Kinawi A; Lüth B
    Arch Pharm (Weinheim); 1979 Apr; 312(4):299-302. PubMed ID: 36054
    [No Abstract]   [Full Text] [Related]  

  • 48. Calcium metabolism and maintenance hemodialysis.
    Wing AJ
    Am Heart J; 1969 Dec; 78(6):836-8. PubMed ID: 5353001
    [No Abstract]   [Full Text] [Related]  

  • 49. [The effect of 1alpha-hydroxycholecalciferol on the abnormal calcium metabolism in hemodialysis patients.--Studies on patients showing low serum calcium and high alkaline phosphatase (author's transl)].
    Asai K; Ohkura T; Sakamoto N; Kawahara H; Yamazaki C
    Nihon Jinzo Gakkai Shi; 1978 Sep; 20(9):967-77. PubMed ID: 713173
    [No Abstract]   [Full Text] [Related]  

  • 50. 1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
    Gotloib L; Mines M; Mazur Y; Sklan D; Garmizo AL; Jancu J; Israeli M; Malul M
    Isr J Med Sci; 1978 Jul; 14(7):731-5. PubMed ID: 681163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of renal osteopathy with 5,6-trans-25-hydroxycholecalciferol (author's transl)].
    Kraft D; Schaefer K; Grigoleit HG; Offermann G; von Herrath D; Delling G
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1706-10. PubMed ID: 520165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of alphacalcidol on calcium and phosphate metabolism in patients treated with hemodialysis].
    Veljković S; Raicević R; Cukaranović R; Ralenković S; Stojanović M; Kostić S; Djordjević V; Radenković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():117-8. PubMed ID: 9102869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The characteristics with regard to the serum alkaline phosphatase in patients under longterm hemodialysis (author's transl)].
    Matsuda Y; Kijima Y; Sasaoka T; Kanayama M
    Rinsho Byori; 1978 May; 26(5):451-6. PubMed ID: 671797
    [No Abstract]   [Full Text] [Related]  

  • 54. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
    Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.